Inactive Instrument
LYSOGENE Share Price
Stocks
LYS
FR0013233475
Biotechnology & Medical Research
OTC Markets Traded
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 09/05/2014 | |
| Director of Finance/CFO | - | 01/11/2022 | |
Marie Trad
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 22/05/2019 | |
Peter Lichtlen
BRD | Director/Board Member | 58 | 01/04/2018 |
Carole Deffez
BRD | Director/Board Member | - | 26/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 55.26L | |
| -4.63% | -2.51% | +106.96% | +124.11% | 455.46Cr | |
| -5.27% | +4.64% | +84.58% | +215.80% | 339.13Cr | |
| -2.69% | -1.24% | -26.67% | -40.22% | 202.64Cr | |
| +8.56% | +2.38% | +146.29% | -38.78% | 192.44Cr | |
| -0.21% | +4.81% | +49.77% | +243.41% | 150.79Cr | |
| -1.79% | -1.31% | +127.92% | -51.41% | 89Cr | |
| +0.87% | -0.69% | -12.14% | +40.88% | 86Cr | |
| +0.38% | +2.99% | -35.69% | -18.23% | 49Cr | |
| -8.82% | +0.59% | +2.66% | - | 47Cr | |
| Average | -1.36% | +3.16% | +49.30% | +59.44% | 179.01Cr | |
| Weighted average by Cap. | -2.05% | +1.95% | +72.25% | +95.17% |
Employees
22
